Literature DB >> 11746104

Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia.

M Vitale1, P Tazzari, F Ricci, M A Mazza, G Zauli, G Martini, L Caimi, F A Manzoli, R Conte.   

Abstract

BACKGROUND: Heparin-induced thrombocytopenia (HIT) is a possible complication of heparin therapy that can evolve with life-threatening thromboembolism, for which early diagnosis is essential. However, the specific laboratory approach to the diagnosis of HIT is still controversial.
METHODS: Sera from 13 patients with HIT, from 15 patients with non-HIT thrombocytopenia, and from 10 normal subjects were used to compare nonfunctional and functional methods to detect anti-heparin:PF-4 antibodies and platelet activation. We used three enzyme-linked immunosorbent assays (ELISAs) and the particle gel immunoassay as nonfunctional tests, and platelet aggregometry, CD62p (p-selectin) phenotypical expression, and Annexin V binding as functional assays.
RESULTS: CD62p expression was positive in 85% of the cases and Annexin V was positive in 40% of the HIT cases examined. Aggregometry gave variable results that depend strongly on the donor.
CONCLUSION: Functional tests for platelet activation are more reliable for HIT diagnosis than the nonfunctional tests. We conclude that the phenotypical expression of p-selectin detected by flow cytometry on activated platelets appears to be a good functional marker for the diagnosis of HIT and its possible thromboembolic complications. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746104     DOI: 10.1002/cyto.1170

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  6 in total

Review 1.  Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors:  Albrecht Leo; Susanne Winteroll
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

2.  A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT.

Authors:  Anand Padmanabhan; Curtis G Jones; Daniel W Bougie; Brian R Curtis; Janice G McFarland; Demin Wang; Richard H Aster
Journal:  Thromb Haemost       Date:  2015-07-16       Impact factor: 5.249

3.  Successful Use of Alternative Anticoagulants in the Management of Heparin-induced Thrombocytopenia with Thrombotic Complications: Report of 5 cases and review of literature.

Authors:  Salam Alkindi; Owen P Smith; Helen Enright
Journal:  Sultan Qaboos Univ Med J       Date:  2011-08-15

4.  Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism.

Authors:  Sara Groeneboer; Stijn Lambrecht; Aad Dhollander; Peggy Jacques; Bert Vander Cruyssen; Rik J Lories; Katrien Devreese; Koen Chiers; Dirk Elewaut; Gust Verbruggen
Journal:  Rheumatology (Oxford)       Date:  2011-02-23       Impact factor: 7.580

Review 5.  Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.

Authors:  Valentine Minet; Jean-Michel Dogné; François Mullier
Journal:  Molecules       Date:  2017-04-11       Impact factor: 4.411

6.  An Optimized and Standardized Rapid Flow Cytometry Functional Method for Heparin-Induced Thrombocytopenia.

Authors:  Anne Runser; Caroline Schaning; Frédéric Allemand; Jean Amiral
Journal:  Biomedicines       Date:  2021-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.